Mindfulness Training for Pregnancy-Related Hypertension
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether mindfulness training can prevent high blood pressure during pregnancy, targeting pregnant women at risk of complications from hypertension. Participants will either receive mindfulness sessions over the phone or continue with their usual prenatal care. The goal is to determine if mindfulness can improve heart health and reduce stress, potentially lowering the risk of pregnancy-related hypertension. Women with a single pregnancy, who are less than 20 weeks along, and at moderate to high risk for hypertension, are ideal candidates for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance prenatal care for future mothers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on mindfulness training as an additional intervention, so it's best to discuss your medications with the trial coordinators or your doctor.
What prior data suggests that mindfulness training is safe for pregnant women?
Research has shown that mindfulness training is safe and well-tolerated for pregnant women. Studies have found it reduces stress, anxiety, and depression without safety concerns. In healthy pregnant women, increased mindfulness was linked to lower blood pressure and improved heart health.
Additionally, mindfulness programs have successfully lowered blood pressure in individuals with hypertension. This evidence suggests that mindfulness training could be a safe option for pregnant women, particularly those at risk for high blood pressure issues.12345Why are researchers excited about this trial?
Unlike the standard treatments for pregnancy-related hypertension, which often involve medications like methyldopa or labetalol, mindfulness training offers a non-pharmacological approach. Researchers are excited about this because it focuses on reducing stress and promoting relaxation through phone-delivered sessions. This method is not only convenient but also empowers expectant mothers to actively manage their condition without the potential side effects of medication. By integrating mindfulness techniques, it holds promise for improving both mental and physical well-being during pregnancy.
What evidence suggests that mindfulness training might be an effective treatment for pregnancy-related hypertension?
This trial will compare mindfulness training with treatment as usual for managing pregnancy-related hypertension. Research has shown that mindfulness training, which participants in this trial may receive, can help lower blood pressure in adults with high blood pressure, including pregnant women. Early studies with pregnant women at risk for high blood pressure-related issues have shown promising results. Specifically, these studies found that mindfulness training not only lowered the mother's blood pressure but also positively affected the baby's growth. While the exact reasons mindfulness helps are still being explored, it seems to reduce stress, which can improve heart health. Although some research has not found a significant impact on blood pressure or preeclampsia rates, the potential benefits make mindfulness a promising non-drug option for managing blood pressure during pregnancy.12356
Who Is on the Research Team?
Margaret H Bublitz
Principal Investigator
The Miriam Hospital
Are You a Good Fit for This Trial?
This trial is for English-speaking pregnant women under 20 weeks' gestation, with blood pressure below 140/90, and at moderate to high risk for hypertensive disorders. It's not for those with multiple pregnancies, severe depression or psychosis, or who regularly practice mind-body activities like yoga or meditation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Measurement of maternal cardiovascular parameters and completion of surveys of daily experiences
Treatment
Participants receive an 8-week phone-delivered mindfulness intervention or usual care
Post-Treatment Assessment
Re-assessment of maternal cardiovascular parameters and completion of surveys of daily experiences
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness training
Mindfulness training is already approved in European Union, United States for the following indications:
- Stress reduction
- Anxiety management
- Depression management
- Stress reduction
- Anxiety management
- Depression management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lifespan
Lead Sponsor